Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends

BMJ (Online)

Volumn 339, Issue 7714, 2009, Pages 206-209

  Jørgensen, Karsten Juhl ^a   Gøtzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AUSTRALIA; BREAST CANCER; CALCULATION; CANADA; CANCER DIAGNOSIS; CANCER INCIDENCE; CARCINOMA IN SITU; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIAGNOSTIC ERROR; HUMAN; LINEAR REGRESSION ANALYSIS; MAMMOGRAPHY; META ANALYSIS; NORWAY; POPULATION SIZE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SWEDEN; SYSTEMATIC REVIEW; UNITED KINGDOM;

AGED; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 68149122164     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2587     Document Type: Review

References (34)

1. Vainio H, Bianchini F. IARC handbooks of cancer prevention vol 7: breast cancer screening. Lyon: IARC Press, 2002.
2. Welch GH. Should I be tested for cancer? California: University of California Press, 2004.
3. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer atypia among young andmiddle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987;56:814-819 (Pubitemid 18048359)
4. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast. Ann InternMed 1997;127:1023-1028
5. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134
6. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;(4):CD001877.
7. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening andmortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-948 (Pubitemid 18245392)
8. Jørgensen KJ, Klahn A, Gøtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 2007;5:12.
9. Statistics Canada. 2008. www12.statcan.ca/english/census06/data/topics/ RetrieveProductTable.cfm?Temporal=2006&PID=88984&GID=838031&METH= 1&APATH=3&P=2006&PID=88984&GID=838031&METH=1&APATH= 3&PTY=88984&GID=838031&METH=1&APATH=3&PTYPE=88971&THE= 838031&METH=1&APATH=3&PTYPE=88971&THEME=66&AID=&= 1&APATH=3&PTYPE=88971&THEME=66&AID=&FREE=0&FO= 3&PTYPE=88971&THEME=66&AID=&FREE=0&FOCUS=&= 88971&THEME=66&AID=&FREE=0&FOCUS=&VID=0&GC=99&G= 66&AID=&FREE=0&FOCUS=&VID=0&GC=99&GK=NA&RL= 0&TPL==0&FOCUS=&VID=0&GC=99&GK=NA&RL=0&TPL= RETR&=&VID=0&GC=99&GK=NA&RL=0&TPL=RETR&SUB=0&d1= 0.
10. Lindgren A, Holmberg L, Thurfjell E. The influence of mammography screening on the pathological panorama of breast cancer. APMIS 1997;105:62-70. (Pubitemid 27504558)
11. NHS. Screening for breast cancer in England: past and future. Publication No 61. Department of Health: NHS cancer screening programmes, 2006. www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp61.html.
12. Johnson A, Shekhdar J. Breast cancer incidence: what do the figures mean? J Eval Clin Pract 2005;11:27-31.
13. Demers AA, Turner D, Mo D, Kliewer EV. Breast cancer trends in Manitoba: 40 years of follow-up. Chronic Dis Can 2005;26:13-19 (Pubitemid 41057882)
14. Chiu C, Morrell S, Page A, Rickard M, Brassil A, Taylor R. Population-based mammography screening and breast cancer incidence in New South Wales, Australia. Cancer Causes Control 2006;17:153-160 (Pubitemid 43121764)
15. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005;117:842-847 (Pubitemid 41598838)
16. Hofvind S, Sorum R, Haldorsen T, Langmark F. [Incidence of breast cancer before and after implementation of mammography screening]. Tidsskr Nor Laegeforen 2006;126:2935-2938
17. NHS Health and Social Care Information Centre. Breast screening programme, England: 2004-2005. www.cancerscreening.nhs.uk/breastscreen/breast- statistics-bulletin-2004-05.pdf.
18. Giles G, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol 2003;14:1209-1211 (Pubitemid 37039044)
19. Luke C, Priest K, Roder D. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening. Asian Pac J Cancer Prev 2006;7:69-74.
20. Sjönell G, Ståhle L. [Health checks withmammography do not reduce breast cancer mortality]. Läkartidningen 1999;96:904-913
21. Hemminki K, Rawal R, Bermejo JL. Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 2004;22:4652-4653 (Pubitemid 41185137)
22. Zahl PH, Strand BH, Mæhlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-924
23. Møller B, Weedon-Fekjær H, Hakulinen T, Tryggvadottir L, Storm HH, Talback M, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev 2005;14:117-128 (Pubitemid 40516973)
24. Douek M, Baum M. Mass breast screening: is there a hidden cost? Br J Surg 2003;90:44-45
25. Boer R, Warmerdam P, de Koning H, van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet 1994;343:979. (Pubitemid 24117251)
26. Svendsen AL, Olsen AH, von Euler-ChelpinM, Lynge E. Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer 2006;106:1883-1890
27. Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006;8:R68.
28. Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, et al. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003;88:362-365 (Pubitemid 36308145)
29. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006;12:338-342 (Pubitemid 43989978)
30. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 2004;11:23-27
31. Zahl PH, Jørgensen KJ, Mæhlen J, Gøtzsche PC. Biases in published estimates of overdetection due to screening with mammography. Lancet Oncol 2008;9:199-201. (Pubitemid 351722941)
32. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333 (Pubitemid 34761611)
33. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670-1674
34. Thorat MA. What caused the decline in US breast cancer incidence? Nat Clin Pract Oncol 2008;5:314-315